Vanguard Group’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$47.2M Buy
2,337,433
+49,243
+2% +$1.19M ﹤0.01% 2190
2025
Q3
$68.9M Buy
2,288,190
+65,444
+3% +$1.42M ﹤0.01% 2005
2025
Q2
$28.7M Buy
2,222,746
+33,526
+2% +$319K ﹤0.01% 2385
2025
Q1
$16M Buy
2,189,220
+5,579
+0.3% +$61.7K ﹤0.01% 2607
2024
Q4
$36.3M Buy
2,183,641
+44,881
+2% +$598K ﹤0.01% 2299
2024
Q3
$27.5M Buy
2,138,760
+33,171
+2% +$480K ﹤0.01% 2442
2024
Q2
$23.5M Buy
2,105,589
+7,877
+0.4% +$91.8K ﹤0.01% 2488
2024
Q1
$26M Buy
2,097,712
+588,953
+39% +$9.82M ﹤0.01% 2464
2023
Q4
$40M Buy
1,508,759
+38,384
+3% +$1.12M ﹤0.01% 2281
2023
Q3
$67.2M Buy
1,470,375
+12,256
+0.8% +$568K ﹤0.01% 1998
2023
Q2
$60.1M Buy
1,458,119
+276,137
+23% +$9.06M ﹤0.01% 2105
2023
Q1
$36.7M Buy
1,181,982
+46,356
+4% +$1.49M ﹤0.01% 2317
2022
Q4
$22.8M Buy
1,135,626
+3,628
+0.3% +$77.6K ﹤0.01% 2557
2022
Q3
$16M Buy
1,131,998
+89,542
+9% +$1.21M ﹤0.01% 2732
2022
Q2
$7.82M Sell
1,042,456
-164,725
-14% -$1.37M ﹤0.01% 3120
2022
Q1
$12.3M Buy
1,207,181
+64,226
+6% +$821K ﹤0.01% 3043
2021
Q4
$27.6M Buy
1,142,955
+117,985
+12% +$2.3M ﹤0.01% 2666
2021
Q3
$14M Buy
1,024,970
+3,188
+0.3% +$22.9K ﹤0.01% 3059
2021
Q2
$2.82M Buy
1,021,782
+16,979
+2% +$40.6K ﹤0.01% 3863
2021
Q1
$2.53M Buy
1,004,803
+85,524
+9% +$221K ﹤0.01% 3809
2020
Q4
$2.33M Buy
919,279
+23,600
+3% +$39.4K ﹤0.01% 3625
2020
Q3
$1.24M Buy
895,679
+77,811
+10% +$144K ﹤0.01% 3607
2020
Q2
$1.6M Buy
817,868
+31,591
+4% +$54.4K ﹤0.01% 3496
2020
Q1
$1.31M Buy
786,277
+274,977
+54% +$530K ﹤0.01% 3425
2019
Q4
$1.02M Buy
511,300
+258
+0.1% +$482 ﹤0.01% 3633
2019
Q3
$914K Sell
511,042
-135,388
-21% -$194K ﹤0.01% 3674
2019
Q2
$1.07M Sell
646,430
-2,601
-0.4% -$4.29K ﹤0.01% 3659
2019
Q1
$895K Buy
649,031
+2,451
+0.4% +$3.31K ﹤0.01% 3658
2018
Q4
$911K Buy
646,580
+5,316
+0.8% +$9.93K ﹤0.01% 3591
2018
Q3
$1.42M Buy
641,264
+17,700
+3% +$43.8K ﹤0.01% 3626
2018
Q2
$1.47M Buy
623,564
+21,600
+4% +$53.3K ﹤0.01% 3584
2018
Q1
$1.35M Buy
601,964
+44,098
+8% +$112K ﹤0.01% 3570
2017
Q4
$1.51M Buy
557,866
+27,424
+5% +$86.9K ﹤0.01% 3504
2017
Q3
$2.17M Buy
530,442
+37,043
+8% +$133K ﹤0.01% 3373
2017
Q2
$1.85M Buy
493,399
+153,816
+45% +$649K ﹤0.01% 3403
2017
Q1
$1.63M Buy
339,583
+212,280
+167% +$799K ﹤0.01% 3446
2016
Q4
$307K Buy
127,303
+11,320
+10% +$32.7K ﹤0.01% 3819
2016
Q3
$373K Buy
115,983
+7,881
+7% +$16.2K ﹤0.01% 3811
2016
Q2
$174K Buy
108,102
+9,087
+9% +$12.8K ﹤0.01% 3966
2016
Q1
$113K Hold
99,015
﹤0.01% 4018
2015
Q4
$186K Buy
99,015
+1,800
+2% +$3.66K ﹤0.01% 4022
2015
Q3
$228K Buy
97,215
+300
+0.3% +$660 ﹤0.01% 4016
2015
Q2
$221K Buy
96,915
+4,203
+5% +$9.55K ﹤0.01% 4033
2015
Q1
$217K Buy
92,712
+400
+0.4% +$1.02K ﹤0.01% 3988
2014
Q4
$235K Hold
92,312
﹤0.01% 3875
2014
Q3
$234K Buy
92,312
+4,600
+5% +$12.1K ﹤0.01% 3867
2014
Q2
$189K Buy
87,712
+8,632
+11% +$20.4K ﹤0.01% 3856
2014
Q1
$225K Buy
+79,080
New +$211K ﹤0.01% 3800

Other funds holding AEHR

Vanguard Group's AEHR Position: Q4 2025 in Review

Vanguard Group increased its Aehr Test Systems (AEHR) stake by 2.2% in Q4 2025, buying an estimated $1.19M and bringing the position to 2,337,433 shares worth $47.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

Vanguard Group first reported a position in AEHR in Q1 2014 and has held it in 48 quarters since. The position peaked at $68.9M in Q3 2025. 150 funds tracked by Wall St. Rank hold AEHR as of Q4 2025.

  • Vanguard Group held 2,337,433 shares of Aehr Test Systems worth $47.2M as of Q4 2025.
  • Vanguard Group bought 49,243 Aehr Test Systems shares in Q4 2025, an estimated $1.19M.
  • Aehr Test Systems made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2190 holding.
  • Vanguard Group first reported a position in Aehr Test Systems in Q1 2014 and has held it in 48 quarters since.
  • Vanguard Group's Aehr Test Systems position peaked at $68.9M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.